Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1513 results found
2022 ∙ NACI
Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada
Recommendation Americas Canada booster dose COVID-19
Download:
2022 ∙ SAGE
Interim recommendations for use of the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19
Position paper COVID-19
Download:
2022 ∙ ACIP
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years
Recommendation Americas United States of America children COVID-19
Download:
2022 ∙ JCVI
JCVI statement on COVID-19 vaccinations in 2022: 21 February 2022
Recommendation Europe United Kingdom COVID-19
Download:
2022 ∙ JCVI
JCVI statement on the adult COVID-19 booster vaccination programme and the Omicron variant
Recommendation Europe United Kingdom COVID-19 variants vaccine effectiveness COVID-19
Download:
2022 ∙ JCVI
JCVI statement on vaccination of children aged 5 to 11 years old
Recommendation Europe United Kingdom children COVID-19
Download:
2022 ∙ JCVI
JCVI updated statement on the COVID-19 vaccination programme for autumn 2022
Recommendation Europe United Kingdom COVID-19
Download:
2022 ∙ NIAC
Medium term strategy for the COVID-19 vaccination programme
Recommendation Europe Ireland booster dose COVID-19
Download:
2022 ∙ NACI
NACI Recommendations on the use of Medicago COVID-19 vaccine (Covifenz)
Recommendation Americas Canada adult vaccination COVID-19
Download:
2022 ∙ NACI
NACI Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age
Recommendation Americas Canada children COVID-19
Download:
Loading...